148 related articles for article (PubMed ID: 30242839)
1. Association between Trichomonas vaginalis and prostate cancer mortality.
Tsang SH; Peisch SF; Rowan B; Markt SC; Gonzalez-Feliciano AG; Sutcliffe S; Platz EA; Mucci LA; Ebot EM
Int J Cancer; 2019 May; 144(10):2377-2380. PubMed ID: 30242839
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
Stark JR; Judson G; Alderete JF; Mundodi V; Kucknoor AS; Giovannucci EL; Platz EA; Sutcliffe S; Fall K; Kurth T; Ma J; Stampfer MJ; Mucci LA
J Natl Cancer Inst; 2009 Oct; 101(20):1406-11. PubMed ID: 19741211
[TBL] [Abstract][Full Text] [Related]
3. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
Sutcliffe S; Alderete JF; Till C; Goodman PJ; Hsing AW; Zenilman JM; De Marzo AM; Platz EA
Int J Cancer; 2009 May; 124(9):2082-7. PubMed ID: 19117055
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.
Chen YC; Huang YL; Platz EA; Alderete JF; Zheng L; Rider JR; Kraft P; Giovannucci E; Sutcliffe S
Cancer Causes Control; 2013 Jan; 24(1):175-80. PubMed ID: 23179660
[TBL] [Abstract][Full Text] [Related]
5. Trichomonas vaginalis infection and risk of advanced prostate cancer.
Shui IM; Kolb S; Hanson C; Sutcliffe S; Rider JR; Stanford JL
Prostate; 2016 May; 76(7):620-3. PubMed ID: 26818005
[TBL] [Abstract][Full Text] [Related]
6. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.
Saleh NE; Alhusseiny SM; El-Zayady WM; Aboelnaga EM; El-Beshbishi WN; Saleh YM; Abou-ElWafa HS; El-Beshbishi SN
Parasitol Res; 2021 Apr; 120(4):1379-1388. PubMed ID: 33159459
[TBL] [Abstract][Full Text] [Related]
7. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses.
Twu O; Dessà D; Vu A; Mercer F; Stevens GC; de Miguel N; Rappelli P; Cocco AR; Clubb RT; Fiori PL; Johnson PJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8179-84. PubMed ID: 24843155
[TBL] [Abstract][Full Text] [Related]
9. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer.
Vicier C; Werner L; Chipman J; Harshman LC; Patil DH; Fichorova RN; Rider JR; Sanda MG; Mucci LA; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):32-37. PubMed ID: 30348512
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection.
Mason PR; Fiori PL; Cappuccinelli P; Rappelli P; Gregson S
Epidemiol Infect; 2005 Apr; 133(2):315-23. PubMed ID: 15816157
[TBL] [Abstract][Full Text] [Related]
11. Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.
Marous M; Huang WY; Rabkin CS; Hayes RB; Alderete JF; Rosner B; Grubb RL; Winter AC; Sutcliffe S
Cancer Causes Control; 2017 Aug; 28(8):889-898. PubMed ID: 28669054
[TBL] [Abstract][Full Text] [Related]
12. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.
Van Der Pol B; Kwok C; Pierre-Louis B; Rinaldi A; Salata RA; Chen PL; van de Wijgert J; Mmiro F; Mugerwa R; Chipato T; Morrison CS
J Infect Dis; 2008 Feb; 197(4):548-54. PubMed ID: 18275275
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Trichomonas vaginalis serostatus in men over time.
Sutcliffe S; Alderete JF; Neace C; Joyce PA; Gaydos CA; Huth JI; Mucci LA; Signorello LB
Cancer Causes Control; 2015 Oct; 26(10):1461-6. PubMed ID: 26223890
[TBL] [Abstract][Full Text] [Related]
14. Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.
Langston ME; Bhalla A; Alderete JF; Nevin RL; Pakpahan R; Hansen J; Elliott D; De Marzo AM; Gaydos CA; Isaacs WB; Nelson WG; Sokoll LJ; Zenilman JM; Platz EA; Sutcliffe S
Prostate; 2019 Oct; 79(14):1622-1628. PubMed ID: 31376187
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis and cervical cancer. A prospective study in China.
Zhang ZF; Graham S; Yu SZ; Marshall J; Zielezny M; Chen YX; Sun M; Tang SL; Liao CS; Xu JL
Ann Epidemiol; 1995 Jul; 5(4):325-32. PubMed ID: 8520717
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men.
Kim JH; Moon HS; Kim KS; Hwang HS; Ryu JS; Park SY
Korean J Parasitol; 2019 Feb; 57(1):21-25. PubMed ID: 30840795
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells.
Han IH; Kim JH; Jang KS; Ryu JS
Prostate; 2019 Jul; 79(10):1133-1146. PubMed ID: 31050003
[TBL] [Abstract][Full Text] [Related]
18. Interaction between
Kim JH; Han IH; Kim SS; Park SJ; Min DY; Ahn MH; Ryu JS
Korean J Parasitol; 2017 Apr; 55(2):213-218. PubMed ID: 28506046
[TBL] [Abstract][Full Text] [Related]
19. Molecular Examination of
Kamarkhani Z; Rafiei-Sefiddashti R; Haghighi L; Badirzadeh A; Hadighi R
Ethiop J Health Sci; 2021 Mar; 31(2):237-240. PubMed ID: 34158774
[TBL] [Abstract][Full Text] [Related]
20. Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia.
Iqbal J; Al-Rashed J; Kehinde EO
BMC Infect Dis; 2016 Sep; 16(1):506. PubMed ID: 27660027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
